FLSM
ADCT icon

Frazier Life Sciences Management’s ADC Therapeutics ADCT Stock Holding History

Frazier Life Sciences Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,647,030
Closed -$1.48M – 50
2023
Q3 		$1.48M Hold
1,647,030
– – 0.1% 49
2023
Q2 		$3.54M Hold
1,647,030
– – 0.21% 45
2023
Q1 		$3.21M Buy
+1,647,030
New +$3.21M 0.23% 46